
Nazli Tokatli
Istanbul Health and Technology University
The fourth industrial revolution in human history is artificial intelligence (AI). Deep learning (DL) is a class of cutting-edge machine learning algorithms that has aroused a lot of attention throughout the world in recent years. DL is a revolutionary AI machine learning technology that has completely transformed the AI sector. DL has demonstrated clinically acceptable diagnostic performance in detecting several retinal disorders in ophthalmology. Future study will be necessary to assess the clinical deployment and cost-effectiveness of various DL systems in clinical practise. To increase clinical acceptance of DL systems, present and future approaches must be used to unravel the ‘black-box' aspect of DL.

Istanbul Health and Technology University
Glaucoma represents a leading cause of irreversible blindness worldwide, characterized by progressive optic nerve damage that often progresses asymptomatically until significant vision loss occurs.…
Background: Artificial Intelligence (AI) tools, particularly Large Language Models (LLMs), are increasingly utilised to provide health information, with patients seeking simplified explanations of…
The rising global burden of vision-threatening conditions highlights the need for scalable, accessible, and accurate screening tools. RetinX is an AI-powered mobile application developed to address…
Background: Most deep learning systems for Diabetic Retinopathy (DR) screening rely on architectures such as ResNet and EfficientNet, with recent attention shifting towards transformer-based models.…
Introduction: Artificial Intelligence (AI) has transformed medicine, with various applications across diagnostics and clinical decision tools that have been applied in many specialties, including…
Purpose: Large language models (LLMs) can accept text and image prompts as multimodal input. With implications for ophthalmology as a field, we evaluated the performance of several LLMs on relevant…
Oral and poster slots for original Artificial Intelligence and Deep Learning in Ophthalmology work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Artificial Intelligence and Deep Learning in Ophthalmology research and practice.
Attend in person in Singapore or join virtually — same program, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Artificial Intelligence and Deep Learning in Ophthalmology track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Artificial Intelligence and Deep Learning in Ophthalmology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Artificial Intelligence and Deep Learning in Ophthalmology are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Artificial Intelligence and Deep Learning in Ophthalmology track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.